Amgen thyroid drug succeeds in late stage kidney patient trial
July 17, 2014 at 16:29 PM EDT
July 17 (Reuters) - An experimental drug to reduce excess parathyroid hormone levels in patients with chronic kidney disease succeeded in meeting the primary and secondary goals of a Phase III study, Amgen Inc said on Thursday.